The Online Investor
Stock Splits
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Stock Splits

By The Online Investor Staff, updated Tue., Oct. 25, 11:28 AM

Slide #3. XOMA Corporation (NASDAQ:XOMA) 1 for 20 Reverse Split

Announced: 10/14/2016
Stock Split: 1 for 20
Record Date: 10/17/2016
Pay Date: 10/18/2016
XOMA Optionable?: Yes

XOMA is a development stage biotechnology company with a portfolio of therapeutic antibodies. Co. has five assets in its endocrine portfolio, two of which were developed as part of its XOMA Metabolism (XMet) platform. XOMA 358 is a fully human negative allosteric modulating insulin receptor antibody that was derived from Co.'s XMet platform. XOMA 129 is a potent fragment of a monoclonal antibody with negative allosteric modulation activity against the insulin receptor. XOMA 213 is an allosteric inhibitor of prolactin action. Gevokizumab is a potent humanized monoclonal antibody with allosteric properties that has the potential to treat patients with a variety of inflammatory diseases.
XOMA Detailed Information Page & Split History »

Company Name:  XOMA Corp
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding XOMA:  1
Total Market Value Held by ETFs:  $6328
Total Market Capitalization:  $33.00M
% of Market Cap. Held by ETFs:  0.02%

Open the XOMA Page at The Online Investor (in a new window) »

October 25, 2016    11:28 AM Eastern
Quotes delayed 20 minutes

Hold (2.40 out of 4)
18th percentile
(ranked lower than approx. 82% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.